×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EOLS – evolus, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EOLS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/20
04:05 pm
eols
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/15
07:59 pm
eols
Evolus Sees Toxin Market Stabilizing, Evolysse Gaining Traction, Raises 2028 Revenue Targets at Conference [Yahoo! Finance]
Low
Report
Evolus Sees Toxin Market Stabilizing, Evolysse Gaining Traction, Raises 2028 Revenue Targets at Conference [Yahoo! Finance]
3/15
01:05 am
eols
Evolus (EOLS) was downgraded by Wall Street Zen from "buy" to "hold".
Low
Report
Evolus (EOLS) was downgraded by Wall Street Zen from "buy" to "hold".
3/12
07:29 pm
eols
How The Narrative On Evolus (EOLS) Is Resetting After Cautious 2025 And 2026 Guidance [Yahoo! Finance]
Low
Report
How The Narrative On Evolus (EOLS) Is Resetting After Cautious 2025 And 2026 Guidance [Yahoo! Finance]
3/9
12:47 pm
eols
Jeuveau (Evolus) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Low
Report
Jeuveau (Evolus) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
3/5
04:22 pm
eols
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting [Yahoo! Finance]
Medium
Report
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting [Yahoo! Finance]
3/4
04:56 pm
eols
Evolus, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Evolus, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
3/4
08:00 am
eols
Evolus (EOLS) had its "buy" rating reaffirmed by BTIG Research. They now have a $13.00 price target on the stock.
High
Report
Evolus (EOLS) had its "buy" rating reaffirmed by BTIG Research. They now have a $13.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/20
07:19 pm
eols
Form 4 Evolus, Inc. For: Mar 20 Filed by: MOATAZEDI DAVID
Low
Report
Form 4 Evolus, Inc. For: Mar 20 Filed by: MOATAZEDI DAVID
3/20
07:19 pm
eols
Form 4 Evolus, Inc. For: Mar 20 Filed by: Avelar Rui
Low
Report
Form 4 Evolus, Inc. For: Mar 20 Filed by: Avelar Rui
3/18
08:00 pm
eols
Form 4 Evolus, Inc. For: Mar 16 Filed by: MOATAZEDI DAVID
Low
Report
Form 4 Evolus, Inc. For: Mar 16 Filed by: MOATAZEDI DAVID
3/18
08:00 pm
eols
Form 4 Evolus, Inc. For: Mar 16 Filed by: Avelar Rui
Low
Report
Form 4 Evolus, Inc. For: Mar 16 Filed by: Avelar Rui
3/13
04:43 pm
eols
Form 8-K Evolus, Inc. For: Mar 13
Low
Report
Form 8-K Evolus, Inc. For: Mar 13
3/3
05:02 pm
eols
Form 10-K Evolus, Inc. For: Dec 31
High
Report
Form 10-K Evolus, Inc. For: Dec 31
3/3
04:30 pm
eols
Form 8-K Evolus, Inc. For: Mar 03
High
Report
Form 8-K Evolus, Inc. For: Mar 03
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
6/4
Form 4/A Evolus, Inc. For: Jun 03 Filed by: Alphaeon Corp
16.7%
11/7 Evolus Announces Pricing of Public Offering of Common Stock 14.3%
7/17 Form 4 Evolus, Inc. For: Jul 15 Filed by: Parschauer Karah Herdman 11.6%
5/17 Form 424B4 Evolus, Inc. 8.0%
8/8 Juvly Aesthetics Continues Its Leadership Expansion with Appointment of a Chief People Officer 6.7%
2/25 Form 10-K Evolus, Inc. For: Dec 31 6.0%
5/21 ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt 5.4%
7/16 Form 8-K Evolus, Inc. For: Jul 15 4.8%
10/15 Evolus Inc (NASDAQ: EOLS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.4%
5/31 Form 4 Evolus, Inc. For: May 31 Filed by: SILVERNAIL LAUREN P 4.2%
11/7 Evolus Announces Pricing of Public Offering of Common Stock 14.3%
7/17 Form 4 Evolus, Inc. For: Jul 15 Filed by: Parschauer Karah Herdman 11.6%
5/17 Form 424B4 Evolus, Inc. 8.0%
8/8 Juvly Aesthetics Continues Its Leadership Expansion with Appointment of a Chief People Officer 6.7%
2/25 Form 10-K Evolus, Inc. For: Dec 31 6.0%
5/21 ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt 5.4%
7/16 Form 8-K Evolus, Inc. For: Jul 15 4.8%
10/15 Evolus Inc (NASDAQ: EOLS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.4%
5/31 Form 4 Evolus, Inc. For: May 31 Filed by: SILVERNAIL LAUREN P 4.2%
TOP News Decliners
5/15
ALPHAEON Corporation sells 4 million shares in Evolus Inc.
-11.2%
8/13 Evolus Inc (NASDAQ: EOLS) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $30.00 price target on the stock. -11.0%
3/17 Form DEF 14A Evolus, Inc. For: May 01 -10.7%
2/25 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.850 ActVsEst 0.380 - Beat -8.6%
3/27 Evolus Inc (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $31.00 to $16.00. They now have a "buy" rating on the stock. -8.0%
3/4 Evolus Provides Update on International Trade Commission (ITC) Case -7.7%
1/9 Form 8-K Evolus, Inc. For: Jan 09 -7.0%
1/10 Form 8-K Evolus, Inc. For: Jan 10 -6.8%
3/3 Evolus to Participate in Barclays 2020 Global Healthcare Conference -6.3%
8/12 Q2/2019 6/30/2019 EPS -1.370 ZacksConsensus -0.960 ActVsEst (0.410) - Miss -6.2%
8/13 Evolus Inc (NASDAQ: EOLS) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $30.00 price target on the stock. -11.0%
3/17 Form DEF 14A Evolus, Inc. For: May 01 -10.7%
2/25 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.850 ActVsEst 0.380 - Beat -8.6%
3/27 Evolus Inc (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $31.00 to $16.00. They now have a "buy" rating on the stock. -8.0%
3/4 Evolus Provides Update on International Trade Commission (ITC) Case -7.7%
1/9 Form 8-K Evolus, Inc. For: Jan 09 -7.0%
1/10 Form 8-K Evolus, Inc. For: Jan 10 -6.8%
3/3 Evolus to Participate in Barclays 2020 Global Healthcare Conference -6.3%
8/12 Q2/2019 6/30/2019 EPS -1.370 ZacksConsensus -0.960 ActVsEst (0.410) - Miss -6.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: